Home › Funds › EVOLVE PRIVATE WEALTH, LLC › MRK
EVOLVE PRIVATE WEALTH, LLC position in MRK
MERCK & CO · Health Care
EVOLVE PRIVATE WEALTH, LLC reported holding 49,138 shares of MRK (MERCK & CO) in its Q3 2026 13F filing — a position valued at US$7.2M, representing 0.34% of its reported portfolio and ranking #43 among its reported holdings. EVOLVE PRIVATE WEALTH, LLC has disclosed MRK holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How EVOLVE PRIVATE WEALTH, LLC's MRK position evolved
EVOLVE PRIVATE WEALTH, LLC first disclosed a stake in MRK in Q4 2025 at 60,015 shares (US$6.4M). The position peaked in Q1 2026 at 64,340 shares, worth US$7.7M. Across 4 filings, EVOLVE PRIVATE WEALTH, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 49,138 shares valued at US$7.2M — a reduction of -2,846 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 60.02K | $6.37M | New |
| Q1 2026 | 64.34K | $7.74M | Add |
| Q2 2026 | 51.98K | $6.72M | Reduce |
| Q3 2026 | 49.14K | $7.18M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRK and 13F data
MRK (MERCK & CO) is a Health Care company. 30 other funds we track also report a position in MRK — the largest reported positions include BlackRock Inc (US$29.17B), Vanguard Group (US$26.77B), VANGUARD CAPITAL MANAGEMENT LLC (US$23.47B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRK
- BlackRock Inc 227.00M sh · $29.17B · Q2 2026
- Vanguard Group 254.32M sh · $26.77B · Q4 2025
- VANGUARD CAPITAL MANAGEMENT LLC 161.51M sh · $23.47B · Q3 2026
- STATE STREET CORP 121.42M sh · $17.75B · Q3 2026
- Wellington Management Group 86.25M sh · $11.08B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 86.25M sh · $11.08B · Q2 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 68.11M sh · $9.90B · Q3 2026
- Geode Capital Management 61.57M sh · $8.93B · Q3 2026
- GEODE CAPITAL MANAGEMENT, LLC 60.74M sh · $7.79B · Q2 2026
- Charles Schwab Investment Management 54.37M sh · $6.99B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 54.37M sh · $6.99B · Q2 2026
- Fidelity Management & Research (FMR) 46.22M sh · $6.72B · Q3 2026
More on EVOLVE PRIVATE WEALTH, LLC
FAQ
How long has EVOLVE PRIVATE WEALTH, LLC held MRK?
EVOLVE PRIVATE WEALTH, LLC has disclosed MRK holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is EVOLVE PRIVATE WEALTH, LLC's current position in MRK?
As of Q3 2026, EVOLVE PRIVATE WEALTH, LLC holds 49.14K shares of MRK (MERCK & CO), valued at $7.18M, representing 0.34% of its reported portfolio and ranking #43.
Has EVOLVE PRIVATE WEALTH, LLC been buying or selling MRK?
In the latest 13F filing (Q3 2026), EVOLVE PRIVATE WEALTH, LLC reduced its position in MRK. The position peaked in Q1 2026 at 64.34K shares.
Which other funds hold MRK?
Other major institutional holders of MRK include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.